Entity Details

Primary name C4B_2
Entity type gene
Source Source Link

Details

PrimaryID100293534
RefseqGene
SymbolC4B_2
Namecomplement component 4B (Chido blood group), copy 2
Chromosome6
Location6p21.3 alternate reference locus
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate2009-04-22
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsCO4B_HUMAN

GO terms

Show/Hide Table
GOName
GO:0001848 complement binding
GO:0004866 endopeptidase inhibitor activity
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005886 plasma membrane
GO:0006954 inflammatory response
GO:0006956 complement activation
GO:0006958 complement activation, classical pathway
GO:0008228 opsonization
GO:0030246 carbohydrate binding
GO:0030424 axon
GO:0030425 dendrite
GO:0030449 regulation of complement activation
GO:0032490 detection of molecule of bacterial origin
GO:0044216 obsolete other organism cell
GO:0045087 innate immune response
GO:0045202 synapse
GO:0070062 extracellular exosome
GO:0072562 blood microparticle
GO:2000427 positive regulation of apoptotic cell clearance

Diseases

Show/Hide Table
Disease IDSourceNameDescription
614379 OMIMComplement component 4B deficiency (C4BD)A rare defect of the complement classical pathway associated with the development of autoimmune disorders, mainly systemic lupus with or without associated glomerulonephritis. The disease is caused by variants affecting the gene represented in this entry.
152700 OMIMSystemic lupus erythematosus (SLE)A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Disease susceptibility is associated with variants affecting the gene represented in this entry. Interindividual copy-number variation (CNV) of complement component C4 and associated polymorphisms result in different susceptibilities to SLE. The risk of SLE susceptibility has been shown to be significantly increased among subjects with only two copies of total C4. A high copy number is a protective factor against SLE.